SPARK Neuro

SPARK Neuro is a leading neuroscience company that collects and quantifies brain data to generate actionable insights across healthcare, national security and media industries.

Powered by our robust neuroanalytic platform and deep expertise in neuroscience, artificial intelligence, software development, and user experience design, SPARK Neuro builds market-disruptive technologies.

SPARK Neuro Medical creates machine-learning based brain health biomarkers to diagnose and monitor neurological disorders as well as refine drug efficacy measurement and clinical trial recruitment. Through a formal collaboration with the Mayo Clinic, SPARK Neuro is developing algorithms for more objective and accurate diagnosis and tracking of neurological disorders, including Alzheimer’s Disease and Traumatic Brain Injuries. In addition to Mayo Clinic, the SPARK team collaborates with the Alzheimer’s Disease Research Center (ADRC) network, New York University, University of California, and University of Massachusetts.

SPARK Neuro Defense creates neuroscience tools to assess cognitive performance and health, counter violent extremism, and enhance intelligence gathering. SPARK's ability to advance scientific discovery and product development is underpinned by extensive Department of Defense funding, US Army Medical awards, and US Air Force contracts.

SPARK Neuro Media quantifies engagement at the subconscious level using biometric measures of emotion, attention and memory to optimize advertising and entertainment through neuromarketing research. Clients include Netflix, Hulu, Paramount, NBC, Universal Pictures, Anheuser-Busch, MillerCoors, General Motors, Barclays, FedEx, Fidelity, Intuit, Procter & Gamble, Chase, Turner, Condé Nast, Capital One, Clorox, Mars, State Farm, and Walmart.